Mediso Enhances Imaging at University Hospital
Mediso recently completed a significant advancement in nuclear medicine technology with the installation of the AnyScan TRIO-TheraMAX SPECT/CT system at the Department of Nuclear Medicine at Heidelberg University Hospital. This state-of-the-art imaging system is specifically engineered to cater to the clinical requirements of theranostic imaging, incorporating vital features for enhanced patient diagnostic processes.
Purpose-Built for Theranostic Imaging
The AnyScan TRIO-TheraMAX SPECT/CT has been meticulously developed for Targeted Radionuclide Therapies, utilizing radioisotopes that emit alpha and beta particles, which also produce gamma photons. These isotopes, such as 177Lu, 225Ac, and 212Pb, are typically more difficult to image compared to the conventional 99mTc. Thus, the TheraMAX is groundbreaking in providing the performance necessary for quantitative imaging and dosimetry, setting a new standard in the field.
Expanding Imaging Capabilities
Professor Dr. Clemens Kratochwil, the lead physician at Heidelberg’s Department of Nuclear Medicine, expressed excitement about the TheraMAX's installation, stating, "The TheraMAX expands the imaging capabilities of our department for radioligand therapy. We are now able to treat patients with a diverse range of novel radiopharmaceuticals that include 177Lu and 225Ac, facilitating significant advancements in individualized patient care. Moreover, it increases our department's capacity for 99mTc-PSMA scans, ensuring patients receive the best possible treatment outcomes."
Advanced Technology Implementation
The features of the TheraMAX are impressive. It is furnished with three large surface detectors that are considerably larger than traditional 12-detector systems, allowing for comprehensive angular coverage surrounding the patient. With 15.9 mm thick NaI crystals, the system significantly enhances sensitivity for high-energy photons. The design includes an arrangement of 123 PMTs per detector head, providing exceptional high spatial resolution that approaches PET-like image quality.
Efficiency in Imaging Procedures
The challenges of whole-body SPECT/CT imaging, particularly in therapies utilizing 225Ac-PSMA, stem from the ultra-low count rate due to the limited radioactive material used in treatments. The TheraMAX addresses this issue with a 300% increase in sensitivity over conventional dual-detector systems. Consequently, it can successfully conduct whole-body scans in under 30 minutes with a minimum effective field of view of 80 cm.
Performance Across Various Applications
While the TheraMAX excels in radioligand therapy, it is also capable of performing effectively in other nuclear medicine procedures. Its high sensitivity enables ultra-fast quantitative total-body SPECT/CT imaging, achieving a length of 2 meters in just 10 minutes for therapies utilizing 177Lu and 99mTc for bone scans.
István Bagaméry, the Managing Director of Mediso Ltd., emphasized the remarkable imaging performance enabled by the newly developed RoboCart™. This innovative motorized cart allows for seamless switching between applications utilizing low and ultra-high energy isotopes, automating the collimator exchange process across all three detector heads simultaneously within a quick timeframe of five minutes.
Conclusion
In conclusion, the installation of the AnyScan TRIO-TheraMAX SPECT/CT at Heidelberg University Hospital marks a crucial step forward in the realm of nuclear medicine, promising to improve diagnostic capabilities and patient care through its innovative technology. Mediso continues to be at the forefront of advancing medical imaging solutions, contributing significantly to the healthcare landscape.
Frequently Asked Questions
What is the AnyScan TRIO-TheraMAX SPECT/CT?
The AnyScan TRIO-TheraMAX SPECT/CT is a cutting-edge imaging system designed specifically for theranostic imaging and Targeted Radionuclide Therapies.
Where was the AnyScan TRIO-TheraMAX installed?
It was installed at the Department of Nuclear Medicine at Heidelberg University Hospital.
What advancements does the TheraMAX offer?
It offers enhanced sensitivity for imaging high-energy gamma photons and improved performance for precise dosimetry with various theranostic isotopes.
How does the TheraMAX improve patient care?
By expanding treatment options with novel radiopharmaceuticals and increasing imaging capacity, it supports more individualized patient treatment strategies.
What is the RoboCart™ feature?
The RoboCart™ is a motorized cart that automates the collimator exchange process across detector heads, simplifying workflows and boosting efficiency.
